Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X

14 May 2019

Abstract excerpt

// Reiko Yoshida 1 , 2 , Chie Watanabe 2 , 3 , Shiro Yokoyama 2 , Mayuko Inuzuka 2 , Junko Yotsumoto 2 , Masami Arai 1 , Seigo Nakamura 2 , 4 and the Registration Committee of the Japanese HBOC consortium 1 Division of Clinical Genetic Oncology, Cancer Institute Hospital, Tokyo, Japan 2 Division of Breast Surgical Oncology, Department of Surgery, Showa University School of Medicine, Tokyo, Japan 3 Department of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Nutrition, Genetics, and Disease
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31143373
DOI: 10.18632/oncotarget.26852

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63XPMID 31143373Read ↗

Prevalence and differentiation of hereditary breast and ovarian cancers in Japan.Semantic proximity Read ↗

Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.Semantic proximity Read ↗

Correlation between the risk of ovarian cancer and BRCA recurrent pathogenic variants in Japan.Semantic proximity Read ↗

Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population.Semantic proximity Read ↗

Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer PatientsSemantic proximity Read ↗

One origin of founder mutations in JapanSemantic proximity Read ↗

The relationship between BRCA-associated breast cancer and age factors: an analysis of the Japanese HBOC consortium database.Semantic proximity Read ↗

Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple-negative breast cancer cohort.Semantic proximity Read ↗

Development of a novel prediction model for carriage of BRCA1/2 pathogenic variant in Japanese patients with breast cancer based on Japanese Organization of Hereditary Breast and Ovarian Cancer registry dataSemantic proximity Read ↗

Clinicopathological features of breast cancer in Ukrainian women with BRCA1 c.181T>G (p.Cys61Gly) variant: a case series.Semantic proximity Read ↗

[Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer].Semantic proximity Read ↗

A high proportion of founder BRCA1 mutations in Polish breast cancer families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.